The Food and Drug Administration yesterday announced a firmware update to reduce the risk of rapid battery depletion and address cybersecurity vulnerabilities in certain Abbott devices that provide pacing for slow heart rhythms and electrical shock or pacing to stop dangerously fast heart rhythms. The update applies to several families of Abbott (formerly St. Jude Medical) implantable cardioverter defibrillators and cardiac resynchronization therapy defibrillators, including certain devices included in a 2016 recall related to premature battery depletion. FDA recommends that all eligible patients receive the firmware update at their next regularly scheduled visit or when appropriate, depending on the preferences of the patient and physician. Firmware is a type of software embedded in the hardware of a medical device.
Daily cybersecurity intelligence reports distributed from the National Health - ISAC for AHA members October 2018
Northern Maine Medical Center – Fort Kent, Maine
AHA Center for Health Innovation Market Scan
Hospitals, insurers, labs, researchers and others are exploring ways blockchain technology can improve business and clinical operations. Many believe the…
Cybersecurity newsletters from H-ISAC for September 2018
View the latest NH-ISAC Daily newsletters August 2018<